aMoon — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
New York, US
KRISTIN MYERS PENG(CHIEF EXECUTIVE OFFICER AND MANAGER)BURKE WISE(VICE PRESIDENT, TREASURER, SECRETARY AND MANAGER)
BoardTREVOR PRICE(MANAGER)SEBASTIAN CALIRI(MANAGER)
Board seatYair Schindel· per SEC Form D · $61.6M raise · filed Apr 2026
Character Bio is a precision medicine company that integrates genomics, longitudinal clinical data, imaging, and AI-based biomarker analysis to identify genetic drivers of progressive polygenic eye diseases such as age-related macular degeneration and glaucoma.
AI & Machine LearningBiotechDigital HealthJersey City, US
Cheng Zhang(Executive Officer, Director)
BoardVivek Garipalli(Director)Nick Olsen(Director)Peter DiLaura(Director)
Co-investorsCantos VenturesCatalio Capital Management, LPDuke Capital PartnersLifeforce CapitalSanofi VenturesCatalio Capital Management+3 more
Lin Health provides virtual, evidence-based behavioral healthcare for people with chronic pain, using the Collaborative Care model and a technology platform to address the underlying causes of pain rather than only symptoms.
Digital HealthHealthtechMental HealthWellness & Fitness
Yehuda Kogan(Founder)in
Co-investorsSaban VenturesShoni Health VenturesViola VenturesOsage Venture PartnersProofpoint Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.